School of Medicine

A federal judge ruled April 14 in favor of WUSTL in an important case against a former faculty member regarding ownership of tissue samples used in research.

Traditional cancer treatments may eventually be replaced with therapies that use the most beneficial drugs possible, regardless of the tumor’s location. More medical news

YamaguchiWashington University orthopaedic surgeon Ken Yamaguchi, M.D., has been elected to the board of directors of the American Academy of Orthopaedic Surgeons (AAOS). He will serve the academy as member-at-large.

The results of a new study at the School of Medicine could eventually have oncologists removing their specialties from their shingles by making therapy based on a tumor’s anatomical location obsolete. When the researchers compared eight different kinds of cancerous tumors, they saw that whether the tumor was, for instance, a breast tumor, lung tumor or colon tumor didn’t correlate to how the cancers interacted with a standard anticancer drug.

SchafferJean Schaffer has won a Clinical Scientists Award in Translational Research from the Burroughs Wellcome Fund (BWF) to support her work on understanding how diabetes contributes to heart failure. Schaffer, associate professor of medicine and of molecular biology and pharmacology, was one of only 10 physician-scientists in the country to receive this year’s award.

John Holloszy and Luigi Fontana are getting ready to launch a investigation into whether calorie restriction can alter the aging process in humans. More medical news

Pain researchers have identified two key components in the pain cascade that may provide targets for more effective pain-relieving drugs with potentially fewer side effects.

Unilateral, or one-sided, lung volume reduction surgery has significant benefits for some emphysema patients, new research at the School of Medicine shows.

Photo by Robert BostonOccupational therapy students teach older adults to use computers.

A newly opened clinical trial will evaluate the use of radioactive implants combined with surgical removal of small sections of lung to treat stage I lung cancer. The first patients are now being enrolled at the School of Medicine, and the trial will soon be opened at centers nationwide.